Marketresearchnews

Sunday, 25 November 2018

India CRO Market Pipeline Review, 2018- Identify Key Business Opportunities

This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the India CRO Market over the forecast period.

Market Synopsis of India CRO Market:

A Contract Research Organization (CRO) offers outsourced services to support R&D functions for pharmaceutical, biotechnology, and health companies. The services may be clinical research, product development such as drug development or process development such as bio analytical assay development. A CRO may also provide management services such as clinical trials management, and pharmacovigilance.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2927

The India CRO market restraints are rising concern for security especially data security and patient security in clinical trials, lack of collaboration between universities and industry. Further, the compromises done by some India CROs on ethical and technical standards are the major market threat.

The India CRO Market growth is expected to flourish at a CAGR of 12.0% during the forecast period.

India has rapidly become one of the preferred destinations for clinical trials owing to its large heterogeneous patient pool, rapidly transforming healthcare market, highly educated physicians and cost competitiveness propels the market growth. In addition, increased investment from foreign companies as well as local market players either individually or in collaboration is likely to boost the market growth during the forecast period. Further, emerging research areas such as diagnostic research are expected to fuel the India CRO market.

Key Players for India CRO Market:

· Quintiles IMS Holdings, Inc.

· Pharmaceutical Product Development

· Siro Clinpharm

· GVK Bio

· Clininvent

· CliniRX Tangent Research

· Ecron Acunova

· Ace Biomed Pvt. Ltd.

· Actimus Biosciences Pvt. Ltd.

· Alkem Laboratories Ltd.

· Actis Biologics Pvt Ltd.

Segments:

India CRO market has been segmented on the basis of service types which comprises clinical trials, product development, process development, post-marketing surveillance, quality monitoring and others. On the basis of therapeutic application; market is segmented into oncology, cardiovascular, neurology, nephrology and urology, and others. On the basis of end users; market is segmented into pharmaceutical/biopharmaceutical companies, medical devices companies and academic institutes.

Regional Analysis of India CRO Market:

The healthcare sector of India is divided between differential geographic regions and states. The South India and western India account for a major share of the Indian CRO market. However of late the CRO industry is shifting to the North. The reasons for this shift is the concentration of regulatory authority such as Director Controller General of India (DCGI) office, Indian Council of Medical Research (ICMR), Directorate General of Foreign Trade (DGFT), Department of Biotechnology (DBT) etc. Also the costs are lower in North India and the genetic pool is more diverse.
Browse Complete 70 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/india-cro-market-2927

Detailed Table of Contents:

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

9 Company Landscape

9.1 Introduction

9.1.1 Mergers Acquisitions

9.1.2 Collaborations

9.1.3 Release/New Product Launches

9.1.4 Other (Expansion, Updates, Partnership)

10 Company Profile

10.1 Quintiles IMS Holdings, Inc.

10.1.1 Company Overview

10.1.2 Product/Business Segment Overview

10.1.3 Financials

10.1.4 Key Developments

10.1.5 SWOT Analysis

...Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Thursday, 22 November 2018

Intravenous Solution Market Pipeline Review, 2018- Identify Key Business Opportunities

Market Scenario:

Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation. These fluids are sterile fluids which protects patients at the time of serious dehydration. There are various type of IV solutions available for use in the market. Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration.

The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1235

Segments:Global Intravenous (IV) Solution Market has been segmented on the basis of type which comprises of total parenteral solution, peripheral parenteral solution. On the basis of nutritional content the market is segmented into amino acid solution, carbohydrates, vitamins & minerals, parenteral lipid emulsion and others. On the basis of end user the market is segmented into hospitals & clinics, ambulatory and home care.

Regional Analysis of Global Intravenous (IV) Solution Market:The global market for Intravenous (IV) Solution is growing rapidly. The market for Intravenous (IV) Solution is growing with the CAGR of 7.69% during the forecast period from 2016-2022. North America accounts for largest market share in 2015 and is expected to reach USD 4,276.5 million in 2016. This growth is attributed to the factors such as high IV consumption number, high prevalence of chronic diseases.
Asia-Pacific region is the fastest growing market for Intravenous (IV) Solution Market, which is expected to grow at a CAGR of 8.34% during the forecast period from 2016 to 2022 is due to the emergence of high-quality and better healthcare infrastructure and institutions in this region.

Key Players for Global Intravenous (IV) Solution Market:Some of the key players in this market are: ICU Medical, Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo), Grifols S.A. (Spain) and others.

Browse Complete 121 Pages Premium Research Report Enabled with 138 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/intravenous-solution-market-1235

Detailed Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

Chapter 4. Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing Prevalence Of The Chronic Diseases

4.2.2 Rise Of Cholera

4.2.3 Growing Acceptance Of Vitamin C Intravenous For Colorectal Cancer

4.3 Restraints

4.3.1 Presence Of Stringent Government Regulations

4.4 Opportunities

4.4.1 Rising Continuous Demand Of Iv Solutions In U.S.

4.5 Challenge

4.5.1 Increasing Vitamin C Intravenous Therapy Prices

4.6 Mega Trends

4.7 Macroeconomic Indicators

...Continued

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Septic Arthritis Market Anticipated To Witness Noteworthy Growth in the Coming Years

Market Synopsis of the Global Septic Arthritis Market

Septic arthritis is a disease caused by a bacterial infection or invasion in the joints leading to inflammation. Symptoms of septic arthritis include redness, heat, and pain in the joints reducing their movement. It is caused by bacteria, viruses, fungi, and parasites. Diabetes, osteoarthritis, gout, rheumatoid arthritis, joint trauma and poor immune function are major risk factors for septic arthritis.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4603

The market for septic arthritis is driven by an increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, availability of cost effective treatment and extensive research and development activities in internal medicine. There is an increasing demand for the new drugs for the treatment of septic arthritis which further fuels the growth of the market.

Bacterial resistance to commonly used antibiotics such as vancomycin may restrain for the growth of the market. Fierce competition among key market players acts as a barrier for the new entrants in the market.

The global septic arthritis market is expected to grow at a CAGR of 7.5% during the forecast period.

Segments of the Global Septic Arthritis Market

The global septic arthritis market is segmented on the basis of diagnosis, treatment, indication, and end user.

On the basis of diagnosis, market is segmented into joint fluid analysis, blood tests, imaging and others. Imaging is further segmented into X-ray, ultrasonography, MRI, and CT scan.

On the basis of treatment, the market is segmented into antibiotics, aspiration of the joint, surgery, and others. Surgery is further segmented into arthrotomy and arthroscopy.

On the basis of indication, the market is segmented into arthritis, hip or knee prosthesis, poor immune function, joint surgery, and others.

On the basis of end user, the market is segmented into orthopedic hospitals, clinics, pharmaceutical companies, and others.

Regional Analysis of the Global Septic Arthritis Market

America is the largest market for septic arthritis owing to the rising prevalence of septic arthritis in the U.S., According to the Center for Disease Control and Prevention, an estimated 78 million (26%) U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. Furthermore, arthritis prevalence was the highest among people 65 years and older, women, and obese population.

Europe is the second largest market for septic arthritis owing to the rising prevalence of rheumatoid arthritis in European countries and availability of funds for research and development activities.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing geriatric population, rising prevalence of chronic disease such as diabetes, and obesity, and changing lifestyles of the people. Diabetes is one of the major problems further creating opportunities for the market growth.

Key Players in the Global Septic Arthritis Market

· Lupin Pharmaceuticals, Inc. (U.S.)

· F. Hoffmann-La Roche Ltd (Swtizerland)

· AbbVie Inc. (U.S.)

· Amgen Inc. (U.S.)

· Bristol-Myers Squibb Company (U.S.)

· Johnson & Johnson Inc. (U.S.)and

· Pfizer (U.S.)

Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/septic-arthritis-market-4603

Detailed Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

...Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/4603

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Sepsis Diagnostics Market size and Key Trends in terms of volume and value 2018

The global market for sepsis diagnostics is expected to reach USD 710 million by the end of the forecasted period and is expected to grow at a CAGR of 8%.

Market Scenario:

Sepsis is a type of life-threatening organ dysfunction arises when the body's response to an infection injures its own tissues and organs. It can be caused due to weakened immune system, chronic illness, kidney or liver disease, cancer and severe wounds. It can be of two types severe sepsis when there’s organ failure and other is septic shock in which there are the symptoms of severe sepsis includes a low blood pressure. The hospital-acquired infections and rising prevalence of sepsis has led to a growing need for its early diagnosis, which is one of the driving factor for sepsis diagnostics market.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2110

Key Players for Global Sepsis Diagnostics Market:

Some of the key players in this market are: bioMérieux, Inc. (US), EKF Diagnostics (UK), Immunexpress (US), T2 Biosystems, Inc. (US), Becton, Dickinson and Company (US), Axis-Shield Diagnostics Ltd. (Scotland), Cube Dx GmbH (Austria), Sandstone Diagnostics, Inc. (US) and others.

Segments:

Global sepsis diagnostics market has been segmented on the basis of technology which comprises molecular diagnostics, biomarkers, immunoassays and others. On the basis of type of product product types; the market is segmented into kits, instruments, blood culture media and others. On the basis of end users the market is segmented into pathology laboratories, specialty clinics, hospitals, diagnostic centers and others.

Regional Analysis of Global Sepsis Diagnostics Market:

Globally North America is the largest market for medical tourism. The North American market for sepsis diagnostics is expected to reach USD 320 million by the end of the forecasted period.

Europe is the second largest market for sepsis diagnostics which is expected to grow at the CAGR of 6.8%. Asia Pacific is expected to be fastest growing region in sepsis diagnostics market.

Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/sepsis-diagnostics-market-2110

Detailed Table of Contents:

1Introduction

1.1 Definition

1.2 Scope Of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s Five Forces Model

4.1.1 Bargaining Power Of Suppliers

4.1.2 Bargaining Power Of Customer

4.1.3 Intensity Of Competitor’s

4.1.4 Threat Of New Entrants

...Continued

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com